News

Pharmabiz3h
PCI may add Pharm D as a qualification for appointment of Registrar of State Pharmacy Councils
PCI may add Pharm D as a qualification for appointment of Registrar of State Pharmacy Councils: Gireesh Babu, New Delhi ...
Pharmabiz3h
SEC recommends to upgrade Corbevax from restricted use in emergency situation to new drug
SEC recommends to upgrade Corbevax from restricted use in emergency situation to new drug: Gireesh Babu, New Delhi Monday, ...
Pharmabiz17m
BioMarin enters agreement to acquire Inozyme Pharma for $270 million
BioMarin Pharmaceutical Inc. and Inozyme Pharma, Inc. announced that BioMarin has entered into a definitive agreement to acquire Inozyme for $4.00 per share in an all-cash transaction for a total ...
Pharmabiz1h
EMA’s ETF recommends updating Covid-19 vaccines to target new LP.8.1 variant
EMA’s ETF recommends updating Covid-19 vaccines to target new LP.8.1 variant: Amsterdam, The Netherlands Monday, May 19, 2025, 10:00 Hrs [IST] European Medicines Agency’s (EMA ...
Pharmabiz2h
Indian Pharmaceutical Congress 2025 calls for registration of participants under four categories
Indian Pharmaceutical Congress 2025 calls for registration of participants under four categories: Our Bureau, Bengaluru Monday, May 19, 2025, 09:00 Hrs [IST] The 74th Indian Pharm ...
Pharmabiz3h
Healthcare sector convinced on precision testing and tech-led monitoring changing medical treatment landscape
Healthcare sector convinced on precision testing and tech-led monitoring changing medical treatment landscape: Nandita Vijayasimha, Bengaluru Monday, May 19, 2025, 08:00 Hrs [IST] ...
Pharmabiz3h
Medical centres in India emphase on protection of sensitive patient data as top priority
Medical centres in India emphase on protection of sensitive patient data as top priority: Nandita Vijayasimha, Bengaluru Monday, May 19, 2025, 08:00 Hrs [IST] Medical centres in t ...
Pharmabiz3h
LUB asks Centre to constitute Drug Tribunal Board to address industry grievances
LUB asks Centre to constitute Drug Tribunal Board to address industry grievances: Peethaambaran Kunnathoor, Chennai Monday, May 19, 2025, 08:00 Hrs [IST] The Laghu Udyog Bharati ( ...
Pharmabiz3d
KPRDO urges govt to exempt drug licenses from stamp duty
The Karnataka Pharma Retailers & Distributors Organization (KPRDO) has underscored the need to review the notices issued to ...
Pharmabiz2d
Indian cos are expanding their presence in RoW markets due to strong demand, less competition: Nilesh Patel
Indian cos are expanding their presence in RoW markets due to strong demand, less competition: Nilesh Patel: Shardul Nautiyal, Mumbai Saturday, May 17, 2025, 08:00 Hrs [IST] India ...
Pharmabiz2d
China pharma advances from ‘imitation to innovation’ to propel global pharma pipelines: Dr Sheryl Ding
China pharma advances from ‘imitation to innovation’ to propel global pharma pipelines: Dr Sheryl Ding: Nandita Vijayasimha, Bengaluru Saturday, May 17, 2025, 08:00 Hrs [IST] ...
Pharmabiz2d
Import of bulk drugs grows around 2 per cent in FY25
Imports of bulk drugs and intermediates to India have seen a growth of 1.8 per cent during the fiscal year 2024-25, even as the quantity has gone up almost 9.3 per cent as compared to the same period ...